Literature DB >> 12132271

[Value of metastases surgery in metastatic renal cell carcinoma].

B G Volkmer1, J E Gschwend.   

Abstract

Metastasectomy in patients with renal cell carcinoma has to be considered as a palliative approach for symptomatic metastases (e.g., pathologic fracture) or as a curative approach in patients with the option for radical resection of all metastases. By modern perioperative management, even extended resections can be performed with limited morbidity and mortality. The survival rate is significantly higher after resection of pulmonary metastases than after resection of extrapulmonary metastases. Solitary metastases show a better prognosis than multiple metastases. Metachronous metastases that develop after a tumor-free interval of at least 12 months after tumor nephrectomy have a better prognosis than earlier metastases. For metastases that are resected with a curative intent, the best long-term results can be achieved after complete or radical resection.

Entities:  

Mesh:

Year:  2002        PMID: 12132271     DOI: 10.1007/s00120-002-0204-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  7 in total

Review 1.  [Therapy strategies for advanced renal cell carcinoma].

Authors:  M Staehler; N Haseke; G Schöppler; T Stadler; C Adam; C G Stief
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

Review 2.  [Metastatic renal cell carcinoma: therapeutic concepts for non-medicinal treatment].

Authors:  C Wiesner; A Haferkamp
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

3.  [Subtrochanteric renal cell carcinoma metastasis: implantation of a femoral head preserving prosthesis].

Authors:  A S Spiro; L Grossterlinden; J Zustin; J M Rueger; M H Priemel
Journal:  Orthopade       Date:  2011-03       Impact factor: 1.087

Review 4.  [Palliative and supportive therapy in cases of renal cell carcinoma].

Authors:  M Kurosch; S Buse; J Bedke; N Wagener; A Haferkamp; M Hohenfellner
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 5.  Surgery for metastatic renal cell cancer.

Authors:  Shomik Sengupta; Bradley C Leibovich; Michael L Blute; Horst Zincke
Journal:  World J Urol       Date:  2005-06-30       Impact factor: 4.226

6.  [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].

Authors:  M May; C Helke; M Bock; B Hoschke
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

7.  Prolonged survival after sequential multimodal treatment in metastatic renal cell carcinoma: two case reports and a review of the literature.

Authors:  John Syrios; Georgios Kechagias; Nicolas Tsavaris
Journal:  J Med Case Rep       Date:  2012-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.